Aug 15, 2025
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®
Aug 13, 2025
New Study from Caris Life Sciences Validates Optimal Sequencing in Informing Therapy Choices for Breast Cancer Subgroups
Aug 12, 2025
Caris Life Sciences Reports Second Quarter 2025 Financial Results
Aug 05, 2025
Caris Life Sciences Publishes Study Showing its Multi-Layer AI-Based Tissue of Origin Predictions are Best-in-Class and Identify when Patients have been Misdiagnosed
Jul 22, 2025
Caris Life Sciences Validates and Extends Findings on Tumor-Infiltrating Clonal Hematopoiesis
Jun 17, 2025
Caris Life Sciences Announces Pricing of Initial Public Offering
May 08, 2025
Caris Life Sciences Appoints Eric Matthews as Chief Business Officer, Biopharma Business Development
May 07, 2025
The Caris Precision Oncology Alliance Welcomes LSU LCMC Health Cancer Center
Apr 24, 2025
Caris Life Sciences Collaborates with Meaningful Insights Biotech Analytics (MiBA) to Advance Oncology Education and Quality of Care
Apr 17, 2025
Caris Life Sciences to Showcase Research Highlighting the Value of Precision Oncology Collaboration at the American Association for Cancer Research Annual Meeting 2025
Apr 07, 2025
Caris Life Sciences Raises $168 Million in Private Capital from Leading Investors to Continue Platform Expansion
Mar 11, 2025
Caris Life Sciences to Highlight Research at 2025 SGO Annual Meeting on Women's Cancer
Feb 11, 2025
Caris Life Sciences Publishes Landmark Study Demonstrating the Superiority of Caris Assure(TM)
Jan 16, 2025
Caris Life Sciences Announces a Strategic Collaboration with Ontada® to Advance Oncology Research and the Adoption of Precision Medicine
Jan 07, 2025
Caris Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 19, 2024
Caris Life Sciences Exceeds 1,000 Published Studies Milestone
Dec 11, 2024
Caris Life Sciences Publishes Large-Scale Study Demonstrating the Critical Role of Next-Generation Sequencing in Microsatellite Instability Testing
Dec 03, 2024
Caris Life Sciences to Showcase Research Highlighting the Clinical Value of Comprehensive Molecular Profiling at the 2024 San Antonio Breast Cancer Symposium
Nov 25, 2024
Caris Life Sciences Showcases Data Demonstrating the Clinical Value of Clonal Hematopoiesis Identification and Subtraction in Liquid Biopsy to Improve the Accuracy of Treatment Recommendations
Nov 21, 2024
Caris Life Sciences Announces Appointment of Dr. Jeffrey Vacirca to Board of Directors